icon-folder.gif   Conference Reports for NATAP  
 
  EASL 45th Annual Meeting
April 14-18, 2010
Vienna, Austria		 Back grey_arrow_rt.gif
 
 
 
MK-5172, the 1st HCV Protease Inibitor with Potent Acyivity Against Resistance Mutations In Vitro
 
 
  Reported by Jules Levin
EASL Apr 14-18 2010 Vienna Austria